Table 2.
B96.11-PAS | b96.11- biotin/streptavidin |
ECL | GAD65Ab RBA |
|
---|---|---|---|---|
Sensitivity (%) (anti-Id-/T1D patients) |
41 (23/56) | 40 (24/61) | 40 (53/134) | 99 |
Specificity(%) (anti-Id+/controls) |
90 (85/95) | 86 (82/95) | 70 (123/177) | 72 |
Peak signal-to-noise ratio | 28 | 23 | 51 | 28 |